Literature DB >> 1085331

H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.

R M Zinkernagel, M B Dunlop, R V Blanden, P C Doherty, D C Shreffler.   

Abstract

Lymphocytic choriomeningitis virus (LCMV) and ectromelia virus-specific T-cell-mediated cytotoxicity was assayed in various strain combinations using as targets peritoneal macrophages which have been shown to express Ia antigens. Virus-specific cytotoxicity was found only in H-2K- or D-region compatible combinations. I-region compatibility was not necessary nor alone sufficient for lysis. Six different I-region specificities had no obvious effect on the capacity to generate in vivo specific cytotoxicity (expressed in vitro) associated with Dd. Low LCMV-specific cytotoxic activity generated in DBA/2 mice was caused by the non-H-2 genetic background. This trait was inversely related to the infectious virus dose and recessive. Non-H-2 genes, possibly involved in controlling initial spread and multiplication of virus, seem to be, at least in the examples tested, more important in determining virus-specific cytotoxic T-cell activity in spleens than are Ir genes coded in H-2.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085331      PMCID: PMC2190371          DOI: 10.1084/jem.144.2.519

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.

Authors:  P C Doherty; R M Zinkernagel; I A Ramshaw
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

2.  Genetic control of the immune response: the effect of non-H-2 linked genes on antibody production.

Authors:  M E Dorf; E K Dunham; J P Johnson; B Benacerraf
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

Review 4.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

5.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

6.  Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.

Authors:  I Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

Review 7.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

8.  The presence of I-region-associated antigens on B cells in molecules distinct from immunoglobulin and H-2K and H-2D.

Authors:  E R Unanue; M E Dorf; C S David; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.

Authors:  P C Doherty; R M Zinkernagel
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Genetic control of the antibody response to poly-L(Tyr,Glu)-poly-D,L-Ala--poly-L-Lys in C3H--CWB tetraparental mice.

Authors:  K B Bechtol; J H Freed; L A Herzenberg; H O McDevitt
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  9 in total

1.  Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses.

Authors:  P C Doherty; R B Effros; J Bennink
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

2.  Postviral neurological syndromes.

Authors:  P O Behan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

3.  Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Authors:  C J Gauntt; P T Gomez; P S Duffey; J A Grant; D W Trent; S M Witherspoon; R E Paque
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

4.  Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.

Authors:  R M Zinkernagel; A Althage; S Cooper; G Kreeb; P A Klein; B Sefton; L Flaherty; J Stimpfling; D Shreffler; J Klein
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

5.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

6.  Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.

Authors:  A M Schmitt-Verhulst; G M Shearer
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

7.  Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D.

Authors:  R M Zinkernagel; T Leist; H Hengartner; A Althage
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

8.  Cytotoxic T-cell response to Ectromelia virus-infected cells. Different H-2 requirements for triggering precursor T-cell induction or lysis by effector T cells defined by the BALB/c-H-2db mutation.

Authors:  R V Blanden; I F McKenzie; U Kees; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.

Authors:  Karen S Slobod; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-04       Impact factor: 2.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.